Sanofi ousts Paul Hudson for Merck KGaA chief after ‘bumpy ride’
1 hour ago · Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo. Following the departure of GSK CEO …
Sanofi Names Merck KGaA's Belen Garijo to Replace Paul
4 hours ago · Sanofi said Belen Garijo, the chief executive of Merck KGaA, would succeed Paul Hudson as CEO after the board of directors decided not to renew Hudson's mandate. The French drugmaker …
BREAKING: Sanofi Replaces CEO Paul Hudson With Merck KGaA’s …
12 hours ago · After multiple pipeline hiccups in 2025, Sanofi has announced that it will replace CEO Paul Hudson with Merck KGaA’s outgoing chief, Belén Garijo, as the French major braces for a post …
Who is Sanofi's new CEO Belén Garijo? | Reuters
3 hours ago · French drugmaker Sanofi on Thursday appointed Belén Garijo as its new chief executive after choosing not to renew the mandate of Paul Hudson.
Sanofi brings back former Merck KGaA CEO Belen Garijo to be CEO
12 hours ago · (Alliance News) - Sanofi SA on Thursday said it has hired the former head of German peer Merck KGaA to be its new chief executive, as its board decides against renewing the contract of …
Merck’s Belén Garijo to become CEO of Sanofi | The Pharmaletter
1 hour ago · French pharma major Sanofi's board of directors has decided not to renew the director mandate of Paul Hudson. As a result, Paul Hudson’s last day as chief executive (CEO) will be on …
Sanofi Names Merck KGaA’s Garijo to Replace Hudson as CEO
5 hours ago · Sanofi SAN0.44%increase; green up pointing triangle said Belen Garijo would succeed Paul Hudson as chief executive officer after the company’s board of directors decided not to renew …
Sanofi Pasteur and Merck (Known as MSD Outside the United States …
Mar 8, 2016 · Sanofi Pasteur MSD makes use of the combined expertise resulting from Sanofi Pasteur and Merck’s research to focus on the development of new vaccines in Europe in order to produce the …
Sanofi: Scheidende Merck-Chefin Garijo übernimmt ab ... - Handelsblatt
4 hours ago · Nach 15 Jahren beim deutschen Pharmakonzern Merck wechselt Belén Garijo zum französischen Konkurrenten Sanofi. Der Vertrag ihres Vorgängers wird nicht verlängert.
Press Release: Belén Garijo to become Chief Executive Officer ... - Sanofi
Feb 12, 2006 · Belén Garijo to become Chief Executive Officer of Sanofi Paris, February 12, 2026. Sanofi's Board of Directors met on February 11, 2026, and decided not to renew the Director …